PI
BEAM icon

PEAK6 Investments’s Beam Therapeutics BEAM Stock Holding History

PEAK6 Investments’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-10,700
Closed -$354K – 3573
2024
Q1 		$354K Buy
+10,700
New +$333K ﹤0.01% 2689
2022
Q4 		– Sell
-6,500
Closed -$310K – 4429
2022
Q3 		$310K Buy
+6,500
New +$371K ﹤0.01% 3321
2021
Q3 		– Sell
-26,000
Closed -$3.35M – 5160
2021
Q2 		$3.35M Buy
+26,000
New +$2.07M 0.01% 1421

Other funds holding BEAM

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MM
MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

PEAK6 Investments's BEAM Position: Q4 2022 in Review

PEAK6 Investments sold out of Beam Therapeutics (BEAM) in Q4 2022, closing a stake of 388 shares — an estimated $18K sold.

PEAK6 Investments first reported a position in BEAM in Q3 2022 and held it in 1 quarter. The position peaked at $18K in Q3 2022. 209 funds tracked by Wall St. Rank hold BEAM as of Q4 2022.

  • PEAK6 Investments reported no remaining Beam Therapeutics position as of Q4 2022 after selling out during the quarter.
  • PEAK6 Investments sold 388 Beam Therapeutics shares in Q4 2022, an estimated $18K.
  • PEAK6 Investments first reported a position in Beam Therapeutics in Q3 2022 and held it in 1 quarter.
  • PEAK6 Investments's Beam Therapeutics position peaked at $18K in Q3 2022.
  • 209 funds tracked by Wall St. Rank held Beam Therapeutics as of Q4 2022.

Based on PEAK6 Investments's 13F filing for Q4 2022, filed 10 Feb 2023.